GATIS score: An innovative prognostic score for rectal neuroendocrine neoplasms

doi:10.3748/wjg.v31.i6.100458

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (237)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

166

Sum=186

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=28

Feb 14, 2025 (publication date) through Feb 6, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastroenterol. Feb 14, 2025; 31(6): 100458
Published online Feb 14, 2025. doi: 10.3748/wjg.v31.i6.100458

GATIS score: An innovative prognostic score for rectal neuroendocrine neoplasms

Daniel Paramythiotis, Dimitrios Tsavdaris, Eleni Karlafti

Daniel Paramythiotis, Dimitrios Tsavdaris, 1^st Propaedeutic Surgery Department, University General Hospital of Thessaloniki AHEPA, Aristotle University of Thessaloniki, Thessaloniki 54636, Greece

Eleni Karlafti, Department of Emergency, University General Hospital of Thessaloniki AHEPA, Aristotle University of Thessaloniki, Thessaloniki 54636, Greece

Eleni Karlafti, 1^st Propaedeutic Department of Internal Medicine, University General Hospital of Thessaloniki AHEPA, Aristotle University of Thessaloniki, Thessaloniki 54636, Greece

Author contributions: Paramythiotis D designed the research; Tsavdaris D and Karlafti E performed the research and analyzed data; Paramythiotis D wrote the letter; Tsavdaris D and Karlafti E revised the letter.

Conflict-of-interest statement: All authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Daniel Paramythiotis, Doctor, Full Professor, 1^st Propaedeutic Surgery Department, University General Hospital of Thessaloniki AHEPA, Aristotle University of Thessaloniki, St. Kyriakidi 1, Thessaloniki 54636, Greece. danosprx@auth.gr

Received: August 16, 2024
Revised: November 11, 2024
Accepted: December 6, 2024
Published online: February 14, 2025
Processing time: 146 Days and 14.6 Hours

Core Tip

Core Tip: The GATIS score enables a more robust prognostic evaluation of patients with rectal neuroendocrine neoplasms. This prognostic score evaluates key factors, such as tumor grade, T stage, tumor size, age, and the prognostic nutritional index, and surpasses traditional models in predicting overall and progression-free survival. This advancement highlights the value of personalized medicine and standardized prognostic evaluations in enhancing patient outcomes and clinical practice.